Major news broke in the iPSC sector last week when Ncardia (Cologne, Germany) and Nanion Technologies (Munich, Germany) signed a joint marketing and sales promotion agreement. Under the terms of partnership, customers of the companies will get access to high-performance instrument platforms from Nanion, coupled with Ncardia’s portfolio of hiPSC-derived cardiac cell types and assay services. [Read more…]
Cryo-Cell Acquires CORD:USE for $14 Million, Enters Public Cord Blood Sector
On June 4, 2018, Cryo-Cell International announced it will be acquiring the hybrid public-private cord blood bank CORD:USE for $14 million. The acquisition’s purposes are to strengthen its cord blood banking services by entering the public cord blood sector and to solidify its role as an industry leader. Learn about the combined commercial entity of Cryo-Cell CORD:USE below.
Cryo-Cell CORD:USE | The Acquisition of CORD:USE
In this article:
Exosome Market Poised for Expansion?
The market for stem cell exosomes is a fast-growth, high potential market. Currently in its early-stages, the market is readily posed for expansion. With a limited number of market competitors and few products in clinical-stage trials, the market is ripe for disruption by new competitors and new technologies. [Read more…]
Exosome Start-up ExoCoBio Inc. raises $26.7M in Series B Funding
-
ExoCoBio is the 4th largest funded exosome startup in the world
-
ExoCoBio is using the funding to advance its exosome pharmaceutical R&D and cosmeceutical business
SEOUL, South Korea, Sept. 12, 2018 — ExoCoBio Inc. announced that it recently raised about $27 million in its series B funding. Top tier Korean investors participated in this round, including Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital, Atinum Investment, GU Equity Partners, QUANTUM Ventures Korea, Platinum technology Investment.
[Read more…]
AI & Blockchain Will Be Major Factors In HealthCare Going Forward
Are you familiar with AI and blockchain? As a stakeholder in healthcare, if you’re not you soon will be, according to Dr. Kala Fleming, an innovation leader at IBM. Fleming, a research scientist, strategist, engineer, and tech startup and hackathon advisor known for designing and implementing initiatives that drive adoption of next-generation technologies, works on digital inclusion across the Caribbean, Africa, and in underserved communities in the U.S. “I also work directly with entrepreneurs, advising on their startups, connecting them to resources or helping them apply emerging technologies like AI and blockchain,” she says. [Read more…]
- « Previous Page
- 1
- …
- 224
- 225
- 226
- 227
- 228
- …
- 338
- Next Page »